290 related articles for article (PubMed ID: 9172421)
1. Mapping of the antigenic determinants of the Leishmania infantum gp63 protein recognized by antibodies elicited during canine visceral leishmaniasis.
Morales G; Carrillo G; Requena JM; Guzman F; Gomez LC; Patarroyo ME; Alonso C
Parasitology; 1997 Jun; 114 ( Pt 6)():507-16. PubMed ID: 9172421
[TBL] [Abstract][Full Text] [Related]
2. Mapping of the linear antigenic determinants from the Leishmania infantum histone H2A recognized by sera from dogs with leishmaniasis.
Soto M; Requena JM; Quijada L; García M; Guzman F; Patarroyo ME; Alonso C
Immunol Lett; 1995 Dec; 48(3):209-14. PubMed ID: 8867853
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of new Leishmania promastigote surface antigens, LaPSA-38S and LiPSA-50S, as major immunodominant excreted/secreted components of L. amazonensis and L. infantum.
Bras-Gonçalves R; Petitdidier E; Pagniez J; Veyrier R; Cibrelus P; Cavaleyra M; Maquaire S; Moreaux J; Lemesre JL
Infect Genet Evol; 2014 Jun; 24():1-14. PubMed ID: 24614507
[TBL] [Abstract][Full Text] [Related]
4. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.
Rodríguez-Cortés A; Ojeda A; López-Fuertes L; Timón M; Altet L; Solano-Gallego L; Sánchez-Robert E; Francino O; Alberola J
Vaccine; 2007 Nov; 25(46):7962-71. PubMed ID: 17942199
[TBL] [Abstract][Full Text] [Related]
6. Leishmania infantum: gene cloning of the GRP94 homologue, its expression as recombinant protein, and analysis of antigenicity.
Larreta R; Soto M; Alonso C; Requena JM
Exp Parasitol; 2000 Oct; 96(2):108-15. PubMed ID: 11052869
[TBL] [Abstract][Full Text] [Related]
7. Leishmania major: molecular cloning, sequencing, and expression of the heat shock protein 60 gene reveals unique carboxy terminal peptide sequences.
Rey-Ladino JA; Joshi PB; Singh B; Gupta R; Reiner NE
Exp Parasitol; 1997 Mar; 85(3):249-63. PubMed ID: 9085922
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the antigenic determinants of the Leishmania infantum histone H3 recognized by antibodies elicited during canine visceral leishmaniasis.
Soto M; Requena JM; Quijada L; Gomez LC; Guzman F; Patarroyo ME; Alonso C
Clin Exp Immunol; 1996 Dec; 106(3):454-61. PubMed ID: 8973612
[TBL] [Abstract][Full Text] [Related]
9. Leucine rich repeats are the main epitopes in Leishmania infantum PSA during canine and human visceral leishmaniasis.
Boceta C; Alonso C; Jiménez-Ruiz A
Parasite Immunol; 2000 Feb; 22(2):55-62. PubMed ID: 10652117
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis.
Carrillo E; Crusat M; Nieto J; Chicharro C; Thomas Mdel C; Martínez E; Valladares B; Cañavate C; Requena JM; López MC; Alvar J; Moreno J
Vaccine; 2008 Mar; 26(15):1902-11. PubMed ID: 18321614
[TBL] [Abstract][Full Text] [Related]
11. Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis.
Boarino A; Scalone A; Gradoni L; Ferroglio E; Vitale F; Zanatta R; Giuffrida MG; Rosati S
Clin Diagn Lab Immunol; 2005 May; 12(5):647-53. PubMed ID: 15879027
[TBL] [Abstract][Full Text] [Related]
12. Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis.
Soto M; Requena JM; Quijada L; Perez MJ; Nieto CG; Guzman F; Patarroyo ME; Alonso C
Clin Exp Immunol; 1999 Feb; 115(2):342-9. PubMed ID: 9933463
[TBL] [Abstract][Full Text] [Related]
13. During canine leishmaniasis a protein belonging to the 83-kDa heat-shock protein family elicits a strong humoral response.
Angel SO; Requena JM; Soto M; Criado D; Alonso C
Acta Trop; 1996 Sep; 62(1):45-56. PubMed ID: 8971277
[TBL] [Abstract][Full Text] [Related]
14. Vaccination of dogs with six different candidate leishmaniasis vaccines composed of a chimerical recombinant protein containing ribosomal and histone protein epitopes in combination with different adjuvants.
Poot J; Janssen LH; van Kasteren-Westerneng TJ; van der Heijden-Liefkens KH; Schijns VE; Heckeroth A
Vaccine; 2009 Jul; 27(33):4439-46. PubMed ID: 19500553
[TBL] [Abstract][Full Text] [Related]
15. Expression of recombinant heat-shock protein 70 of MCAN/IR/96/LON-49, a tool for diagnosis and future vaccine research.
Rasouli M; Zavaran Hoseini A; Kazemi B; Alborzi A; Kiany S
Iran J Immunol; 2009 Jun; 6(2):75-86. PubMed ID: 19561376
[TBL] [Abstract][Full Text] [Related]
16. Canine visceral leishmaniasis: asymptomatic infected dogs as a source of L. infantum infection.
Moshfe A; Mohebali M; Edrissian G; Zarei Z; Akhoundi B; Kazemi B; Jamshidi S; Mahmoodi M
Acta Trop; 2009 Nov; 112(2):101-5. PubMed ID: 19595664
[TBL] [Abstract][Full Text] [Related]
17. Mapping of the linear antigenic determinants of the Leishmania infantum hsp70 recognized by leishmaniasis sera.
Quijada L; Requena JM; Soto M; Gómez LC; Guzman F; Patarroyo ME; Alonso C
Immunol Lett; 1996 Sep; 52(2-3):73-9. PubMed ID: 8905399
[TBL] [Abstract][Full Text] [Related]
18. Mapping human T cell epitopes in leishmania gp63. Identification of cross-reactive and species-specific epitopes.
Russo DM; Jardim A; Carvalho EM; Sleath PR; Armitage RJ; Olafson RW; Reed SG
J Immunol; 1993 Feb; 150(3):932-9. PubMed ID: 7678627
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Leishmania (Leishmania) infantum Ecto-Nucleoside Triphosphate Diphosphohydrolase NTPDase-2 as a new antigen in canine visceral leishmaniasis diagnosis.
de Souza RF; Dos Santos YL; de Souza Vasconcellos R; Borges-Pereira L; Caldas IS; de Almeida MR; Bahia MT; Fietto JL
Acta Trop; 2013 Jan; 125(1):60-6. PubMed ID: 23022017
[TBL] [Abstract][Full Text] [Related]
20. Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.
Ramos I; Alonso A; Marcen JM; Peris A; Castillo JA; Colmenares M; Larraga V
Vaccine; 2008 Jan; 26(3):333-44. PubMed ID: 18093705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
